MGNX
MacroGenics Inc
4.10$
+0.2%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +106.6% | -13.4% | +20.1% | -11.2% | -5.9% | +21.2% | -11.5% | -13.6% | +3.1% | -12.3% | -1.8% | |
| – | +107.8% | -17.1% | +13.5% | -16.5% | -10.9% | +30.4% | -10.6% | -20.5% | +13.1% | -13.5% | +1.1% | |
| – | +24.5% | -57.1% | +151.8% | +4.0% | -42.5% | +43.2% | -31.8% | -11.8% | -7.3% | +81.1% | -68.7% | |
| – | +115.1% | -18.3% | +10.2% | -23.7% | -7.3% | +26.3% | -10.6% | -36.6% | +48.9% | -12.2% | -5.8% | |
| – | -58.3% | +125.8% | +393.6% | +116.8% | -56.9% | +81.1% | -55.0% | +441.3% | -81.6% | -58.4% | +210.4% | |
| – | – | – | – | – | – | +0.0% | +438,799,900.0% | -66.9% | -15.9% | -100.0% | – | |
| – | +118.7% | +21.0% | +178.3% | +13.5% | +20.6% | -38.3% | -10.8% | -21.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -12.7% | -7.4% | +75.6% | +19.6% | -8.3% | +1.2% | +15.4% | +54.2% | -1.1% | -0.1% | +38.2% | |
| – | -10.7% | +12.8% | +82.2% | +20.5% | -24.6% | +12.2% | +47.2% | -34.8% | +15.4% | -1.0% | -22.4% | |
| – | +23.0% | -21.1% | -81.3% | +11,322.5% | -91.1% | +32.1% | +17.3% | +1.0% | -20.1% | +28.8% | +6.4% | |
| – | +77.8% | +34.6% | -38.6% | +63.4% | +7.6% | +86.4% | +93.0% | -68.4% | +31.5% | -22.2% | -4.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +158.3% | -14.2% | +11.3% | -18.8% | -5.0% | +28.3% | -19.0% | -40.7% | +7.5% | -24.0% | -52.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +16.1% | +9.1% | +4.1% | +13.4% | +17.5% | +9.1% | +14.3% | +2.5% | +0.8% | +1.1% | +0.9% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.